Literature DB >> 9606654

[Therapeutic use of botulinum toxin in otorhinolaryngology. 2. Movement disorders of craniocervical musculature (except for mimetic musculature) and disorders of the autonomic nervous system].

R Laskawi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9606654     DOI： 10.1007/s001060050255

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  4 in total

1.  [Botulinum toxin in the head and neck region].

Authors:  R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 2.  [Botulinum toxin treatment in the head and neck region: current aspects, developments, and problems].

Authors:  R Laskawi
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

3.  [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].

Authors:  O Guntinas-Lichius
Journal:  HNO       Date:  2003-06-17       Impact factor: 1.284

4.  Surgical and conservative methods for restoring impaired motor function - facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing).

Authors:  R Laskawi; S Rohrbach
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.